Kater Arnon, Henke Markus O, Rubin Bruce K
Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1081, USA.
Ann N Y Acad Sci. 2007 Sep;1112:140-53. doi: 10.1196/annals.1415.006. Epub 2007 May 11.
Mucus clearance is the first line of pulmonary defense against inhaled irritants, microorganisms, and allergens. In health, the gel-forming mucins are the principal polymeric components of airway mucus but in cystic fibrosis (CF), the necrotic death of inflammatory and epithelial cells releases a network of copolymerized extracellular DNA and filamentous (F-) actin-producing secretions that are similar to pus and difficult to clear by cilia or airflow. The large amounts of F-actin in CF sputum suggested that thymosin beta4 (Tbeta4) or gelsolin could depolymerize the secondary polymer network of CF sputum. Dose-dependent CF sputum rheology and polymer structure were measured before and after the addition of excipient, dornase alfa, Tbeta4, gelsolin, and Tbeta4 or gelsolin with dornase for 30 min. Sputum was also incubated with Tbeta4 30 microg/mL, gelsolin 10 microg/mL or excipient for 0, 5, 10, 15, 20, or 60 min. There was a dose-dependent decrease in cohesivity with Tbeta4 and a time-dependent decrease in cohesivity at 30 microg/mL. With the combination of dornase alfa and Tbeta4 at 1.5 microg/mL, there was a 65% decrease in elasticity (P = 0.013). There was a time-dependent decrease in cohesivity (P = 0.0004) and elasticity (P = 0.047) with gelsolin and a dose-dependent fall in cohesivity (P = 0.0008). An apparent synergy of Tbeta4 or gelsolin on actin and dornase on DNA may be explained by the combined effect of actin depolymerization and DNA filament severing or by virtue of actin depolymerization increasing the effectiveness of dornase alfa.
黏液清除是肺部抵御吸入性刺激物、微生物和过敏原的第一道防线。在健康状态下,形成凝胶的黏蛋白是气道黏液的主要聚合物成分,但在囊性纤维化(CF)中,炎症细胞和上皮细胞的坏死性死亡会释放出一种由细胞外DNA和丝状(F-)肌动蛋白产生的分泌物共聚而成的网络,这种分泌物类似于脓液,难以通过纤毛或气流清除。CF痰液中大量的F-肌动蛋白表明,胸腺素β4(Tβ4)或凝溶胶蛋白可以使CF痰液的二级聚合物网络解聚。在添加赋形剂、重组人脱氧核糖核酸酶(dornase alfa)、Tβ4、凝溶胶蛋白以及Tβ4或凝溶胶蛋白与dornase联合使用30分钟前后,测量了剂量依赖性的CF痰液流变学和聚合物结构。痰液还分别与30μg/mL的Tβ4、10μg/mL的凝溶胶蛋白或赋形剂在0、5、10、15、20或60分钟进行孵育。Tβ4使内聚性呈剂量依赖性降低,在30μg/mL时内聚性呈时间依赖性降低。dornase alfa与1.5μg/mL的Tβ4联合使用时,弹性降低了65%(P = 0.013)。凝溶胶蛋白使内聚性呈时间依赖性降低(P = 0.0004)和弹性降低(P = 0.047),内聚性呈剂量依赖性下降(P = 0.0008)。Tβ4或凝溶胶蛋白对肌动蛋白的作用与dornase对DNA的作用之间明显的协同作用,可能是由于肌动蛋白解聚和DNA细丝切断的联合效应,或者是由于肌动蛋白解聚提高了dornase alfa的有效性。